BioSpace News Archive

Castle Biosciences, Inc. (Nasdaq: CSTL) today announced the publication of real-world clinical utility data in Cancer Investigation showing that clinicians are ordering DecisionDx®-SCC for the intended high-risk cutaneous squamous cell carcinoma (SCC) patient population and that use of the test’s results can lead to risk-aligned changes in patient management strategies.

Lantern Pharma Inc. today announced that it will host its third quarter 2022 financial results webcast on Monday, November 7, 2022 at 4:30 p.m. Eastern Time.

Abiomed (Nasdaq: ABMD) announces that Impella RP Flex with SmartAssist has received U.S. Food and Drug Administration (FDA) pre-market approval (PMA), the FDA’s highest level of approval, as safe and effective to treat acute right heart failure for up to 14 days.

Thermo Fisher Scientific Inc. (NYSE: TMO) (“Thermo Fisher”), the world leader in serving science, today provided an update on capital deployment.

Siemens Healthineers and UHealth - University of Miami Health System announced a Value Partnership1 agreement.

Mosaic ImmunoEngineering, Inc. announced that two research grants totaling $4.3 million from the National Cancer Institute were awarded to the Company’s collaborating scientists and their respective academic institutions.

Glenmark Pharmaceuticals Inc., USA (Glenmark) is pleased to announce it has launched their Fingolimod Capsules, 0.5 mg, the generic version of Gilenya ®1 Capsules, 0.5 mg, of Novartis Pharmaceuticals Corporation.

SplicingCodes, BioTailor Inc announced that a human individual encodes at least a thousand hereditary fusion genes, contributing to an estimated 85% of the total human inheritance variances.

Brightwork Health IT (Brightwork), an IT consultancy that helps healthcare organizations with large-scale IT implementations, digital transformation initiatives, and technical resources, announced today that its work to transform Summa Health’s utilization of the Epic health record system has been completed.

ModifyHealth™ a nationwide provider of virtual dietitian support and Monash University Certified gut-friendly, Low FODMAP, gluten-free and Mediterranean meals announced today new data related to the clinical impact of ModifyHealth’s Low FODMAP meal delivery service and program that were presented in poster sessions at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting.